Basic principles of contemporary chemotherapy of malignant gliomas of the brain

The modern view on the place of antiblastic chemotherapy in clinical neuro-oncology based on NCCN 2021 clinical guidelines (The National Comprehensive Cancer Network), EANO recommendations (The European Association for Neuro-Oncology), cIMPACT-NOW (The Consortium for Inform Molecular and...

Full description

Bibliographic Details
Main Author: Oleksandr Ya. Glavatskyi
Format: Article
Language:English
Published: Romodanov Neurosurgery Institute 2022-09-01
Series:Ukrainian Neurosurgical Journal
Online Access:https://theunj.org/article/view/258545
_version_ 1797350819618619392
author Oleksandr Ya. Glavatskyi
author_facet Oleksandr Ya. Glavatskyi
author_sort Oleksandr Ya. Glavatskyi
collection DOAJ
description The modern view on the place of antiblastic chemotherapy in clinical neuro-oncology based on NCCN 2021 clinical guidelines (The National Comprehensive Cancer Network), EANO recommendations (The European Association for Neuro-Oncology), cIMPACT-NOW (The Consortium for Inform Molecular and Practical Approaches to CNS Tumor Taxonomy) and many years of experience of the department of adjuvant treatment for the central nervous system tumors of the State Institution "Romodanov Neurosurgery Institute, Ukraine" is presented and the basic principles of its application in the complex treatment of malignant gliomas of the brain are substantiated. Malignant gliomas are a heterogeneous group of the most numerous primary tumors of the central nervous system, differing in both the grade of malignancy and the prognosis of the disease. The latest WHO tumors classification 2021 defines this group of tumors as "diffuse gliomas" of the brain, that is, the term itself indicates infiltrative nature of their growth, that limits the possibility of surgical removal and requires a multimodal approach to their treatment in order to maximize the reduction of tumor tissue. The new era of chemotherapy in neuro-oncology, as well as in general oncology, began with the study of the molecular profile of tumors, which is important both for predicting the course of the disease and for choosing tactics of chemotherapeutic treatment of malignant gliomas. It’s enough to give the following example: in the absence of IDH gene mutation and co-deletion of chromosome 1p/19q loci in grade 2 of anaplasia diffuse gliomas, the prognosis of the disease does not differ from that in glioblastoma multiforme. For the same reason, in modern neuro-oncology, the designation of molecular genetic markers in malignant gliomas is essential for the personification of the treatment of pathology is essential to personalize the treatment of this pathology.
first_indexed 2024-03-08T12:51:42Z
format Article
id doaj.art-a583819b75e44f5b8bce30b1fe49c396
institution Directory Open Access Journal
issn 2663-9084
2663-9092
language English
last_indexed 2024-03-08T12:51:42Z
publishDate 2022-09-01
publisher Romodanov Neurosurgery Institute
record_format Article
series Ukrainian Neurosurgical Journal
spelling doaj.art-a583819b75e44f5b8bce30b1fe49c3962024-01-20T09:13:02ZengRomodanov Neurosurgery InstituteUkrainian Neurosurgical Journal2663-90842663-90922022-09-012833810.25305/unj.258545Basic principles of contemporary chemotherapy of malignant gliomas of the brainOleksandr Ya. Glavatskyi0https://orcid.org/0000-0003-0889-9762Romodanov Neurosurgery Institute, Kyiv, Ukraine The modern view on the place of antiblastic chemotherapy in clinical neuro-oncology based on NCCN 2021 clinical guidelines (The National Comprehensive Cancer Network), EANO recommendations (The European Association for Neuro-Oncology), cIMPACT-NOW (The Consortium for Inform Molecular and Practical Approaches to CNS Tumor Taxonomy) and many years of experience of the department of adjuvant treatment for the central nervous system tumors of the State Institution "Romodanov Neurosurgery Institute, Ukraine" is presented and the basic principles of its application in the complex treatment of malignant gliomas of the brain are substantiated. Malignant gliomas are a heterogeneous group of the most numerous primary tumors of the central nervous system, differing in both the grade of malignancy and the prognosis of the disease. The latest WHO tumors classification 2021 defines this group of tumors as "diffuse gliomas" of the brain, that is, the term itself indicates infiltrative nature of their growth, that limits the possibility of surgical removal and requires a multimodal approach to their treatment in order to maximize the reduction of tumor tissue. The new era of chemotherapy in neuro-oncology, as well as in general oncology, began with the study of the molecular profile of tumors, which is important both for predicting the course of the disease and for choosing tactics of chemotherapeutic treatment of malignant gliomas. It’s enough to give the following example: in the absence of IDH gene mutation and co-deletion of chromosome 1p/19q loci in grade 2 of anaplasia diffuse gliomas, the prognosis of the disease does not differ from that in glioblastoma multiforme. For the same reason, in modern neuro-oncology, the designation of molecular genetic markers in malignant gliomas is essential for the personification of the treatment of pathology is essential to personalize the treatment of this pathology.https://theunj.org/article/view/258545
spellingShingle Oleksandr Ya. Glavatskyi
Basic principles of contemporary chemotherapy of malignant gliomas of the brain
Ukrainian Neurosurgical Journal
title Basic principles of contemporary chemotherapy of malignant gliomas of the brain
title_full Basic principles of contemporary chemotherapy of malignant gliomas of the brain
title_fullStr Basic principles of contemporary chemotherapy of malignant gliomas of the brain
title_full_unstemmed Basic principles of contemporary chemotherapy of malignant gliomas of the brain
title_short Basic principles of contemporary chemotherapy of malignant gliomas of the brain
title_sort basic principles of contemporary chemotherapy of malignant gliomas of the brain
url https://theunj.org/article/view/258545
work_keys_str_mv AT oleksandryaglavatskyi basicprinciplesofcontemporarychemotherapyofmalignantgliomasofthebrain